Ovarian cancer research remains underfunded nationally. With the help of a generous gift, Cleveland Clinic hopes to answer questions that may not be addressed otherwise.
Management of Pregnant Women With COVID-19 Infection Proves Complex
Pregnant women with COVID-19 are at higher risk for hospitalization than nonpregnant women with COVID-19, though risk of death is the same in both populations. Reproductive infectious disease expert Oluwatosin Goje, MD, discusses preterm delivery and other complications of COVID-19 in pregnancy.
Rethinking the Delivery of Ob/Gyn Care
Ob/Gyn virtual visits are up 960% compared with 2019. This article provides an inside look at the rapid adoption of digital health and what we should expect going forward.
First Fetal Surgery Cases Set the Course for a Full Spectrum of Intrauterine Therapies
Since its first procedure in February 2019, a multidisciplinary team has completed15 carefully timed fetal surgeries, saving lives and minimizing risk for life-long disability.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Rigor and Opportunity in Tracking Residency Program
New fellowship programs in obstetrics and gynecology, Transgender Medicine and Surgery, and Maternal-Fetal Medicine, complement a robust and unique education offering.
Complicated Pregnancies Benefit From a Team Approach
Maternal-fetal medicine specialist Edward Chien, MD, MBA, shares new initiatives aimed at improving the health of pregnant women and delivering healthy babies:
Prenatal Group Program Improves Pregnancy Outcomes
Centering approach to prenatal care lowers rate of preterm birth and increases breastfeeding. Maternal-fetal medicine specialist, Edward Chien, MD, MBA, discusses the growing program and how it has adapted to the challenges posed by the COVID-19 pandemic.
Uninterrupted Culture in Time-Lapse Incubator Supports Human Embryonic Development
In vitro fertilization (IVF) has been vastly improved over the past few years with a transition to blastocyst state cryopreservation and transfer. Fertility experts Nina Desai, MD, and Elliot Richards, MD, share insights from the largest, prospective, randomized study to date of embryo development and live birth rates between sibling embryos cultured in two different single-step media.
Extended Use of Pegylated Liposomal Doxorubicin Offers Clinical Benefit With Acceptable Toxicity in Women with Recurrent Ovarian Cancer
A new study shows continued use of pegylated liposomal doxorubicin is well-tolerated and effective in patients with recurrent epithelial ovarian cancer. Gynecologic oncologist Robert DeBernardo, MD, explains.
Second Live Birth From a Deceased Donor Transplant at Cleveland Clinic
For the second time in its clinical trial, a Cleveland Clinic patient has given birth after receiving a transplanted uterus from a deceased donor. In this article, Ob/Gyns on the transplant team provide a closer look at the transplant procedure and fertility treatments provided to a patient with MRKH syndrome.